 Home > Active Ingredient News >

Immunology News

Sci Adv: Heavyweight! Chinese scientists' successful conversion of the spleen into a liver-like organ could solve the dilemma facing liver organ transplantation.

 Time of Update: 2020-06-16

issues science technology different types chromatography ideal com target birmingham al stages liver disease

JUNE 14, 2020 /PRNewswire/ -- In a recent study published in the international journal Science Advances, scientists from Nanjing University and other institutions have developed a new method or can in
J Hosp Infect: Shocked! Viral DNA spreads rapidly on the surface of the hospital ward, remaining for more than 5 days!

 Time of Update: 2020-06-16

high aldolase treatment test multiple sclerosis surface area volume find surface area ph human body

JUNE 14, 2020 /PRNewswire/ -- A new study by University College London (UCL) and Great Ormond Street Hospital and GOSH shows that viral DNA left on bed railings on a hospital bed railing was found at
New psoriasis drug! AbbVie Skyrizi head-to-head Phase III efficacy beat Novartis Cosentyx (good ness): Peel damage completely cleared more!

 Time of Update: 2020-06-16

autoimmune ear disease hydrophobic head 1 2 3 4 isotretinoin 40 mg natural skin bleaching

June 13, 2020 /PRNewswire/ -- AbbVie recently released new data from the Psoriasis Head-to-Head IIIb IMMerge Study (NCT03478787) at the American Society of Dermatology (AAD) online meeting The study w
EU regulators begin review of LEO's IL-13 monoanti-tralokinumab to treat adhetular dermatitis

 Time of Update: 2020-06-16

proteinase 3 antibody research development il 2 cytokine il 2 receptor 1 2 crown

The Eu drug regulator has begun a review of LEO Pharma's leukocyte interleukin 13 (IL-13) monoanti-tralokinumab treatment for moderate to severe adhesional dermatitis The drug is an all-human monocl
Ann Rheum Dis: Prevalence of COVID-19 in patients with chronic inflammatory and autoimmune rheumatism

 Time of Update: 2020-06-16

spss data analysis anti inflammatory drugs name inflammatory intestinal disease 1 2 dichloroethane 1 2 dca

The risk or benefit of COVID-19 susceptibility and immunosuppressive therapy in patients with rheumatism is not yet known The researchers conducted a retrospective study of patients in the rheumatol
AAD 2020:Phase 3 Clinically Proven IL-17A/IL-17F Monoantikizumab Treatment Psoriasis, Better Than IL-12/IL-23 Single Antiustekinumab

 Time of Update: 2020-06-16

3 16 mm inflammatory cytokines citrate test results clinitest positive results cocaine effects skin

At the 2020 American Society of Dermatology (AAD) annual meeting, UCB released for the first time its Bimekizumab (IL-17A and IL-17F monotorther) clinical studies for adult patients with moderate to
Rheumatoid arthritis (RA) first antibody drug coupling (ADC)! Abbvie ABBV-3373 Proof of Concept II study successfully!

 Time of Update: 2020-06-16

type wire stp drug ps 12 3 ether drug cardiac viability study

JUNE 11, 2020 /PRNewswire/ -- AbbVie has released new data from abbV-3373 for the treatment of moderate to severe rheumatoid arthritis (RA) adult patients (M16-560) ABBV-3373 is a new antibody conjuga
Ann Rheum Dis: Effects of rheumatoid arthritis on major cardiovascular events in patients with coronary heart disease and non-coronary heart disease

 Time of Update: 2020-06-16

ra factor positive 7 35 simplified 1 3 7 trimethylxanthine 2 1 4 mm 5 7 paper

Rheumatoid arthritis (RA) is a risk factor for cardiovascular disease The clinical outcomeof both RA and coronary heart disease (CAD) is not clear The purpose of this study was to assess the effecto
Nat Microbiol: How to fight salmonella infection by targeting specific tissue proteases?

 Time of Update: 2020-06-16

mn molecular weight lab chip journal immune system antibodies innate immune system molecular pump

June 13, 2020 /PRNewswire/ -- When the human body is infected with a pathogenic bacteria, the body's immune system tries to destroy the intruder, one way is to initiate an inflammatory response, i.e a
J Cutan Med Surg: Vaccination guidelines for immunosuppressive patients with immunosuppressive diseases

 Time of Update: 2020-06-16

use chlorine long salmonella live jardiance drug class pink drug sale long spider plants live

Patients with immunosuppressive diseases have more infectious episodes than healthy people, but the vaccination practices of doctors for this group of patients are still not satisfactory The purpose
InD application for treatment of rheumatoid arthritis in interstitial stem cell BX-U001, approved by FDA

 Time of Update: 2020-06-16

united states industries gpi drug gbl drug lyrica drug veratril drug

Baylx announced that the U.S Food and Drug Administration (FDA) has approved a new research drug (IND) application for its fresh non-frozen human umbilical cord interstitial stem cell (hUC-MSC) produ
Clin Microbiol Infect: The Effect of Vaccines on Heterogeneous Adaptive Immunity

 Time of Update: 2020-06-16

french number system amount aluminum vaccines garlic immune system cell activation fuel cells future

Vaccines induce antigen-specific memory of adaptive immune cells, thus achieving long-term protection against the target pathogen In addition, some vaccines have more beneficial effects than the prot
Ann Rheum Dis: Characteristics associated with COVID-19 hospitalization in patients with rheumatism

 Time of Update: 2020-06-16

niacinamide use eliquis 10 mg clotting factor 2 phosphoinositide 3 kinase fluticasone use

Little is known about the outcome of COVID-19 infection in patients with rheumatism The purpose of this study was to analyze the demographic and clinical studies associated with COVID-19 hospitalizat
Arthritis Rheumatol: Incidence of COVID-19 in patients with rheumatic disease sedatiat ingested immunosuppressants

 Time of Update: 2020-06-16

wound infection treatment connective tissue images 2 4 label use miconazole 7 anti hiv drugs

The study was designed to describe the incidence and severity of 2019 coronavirus disease (COVID-19) in patients with rheumatoid diseases treated with synthetic or bio-anti-rheumatoid drugs (ts/bDMAR
Sword refers to the heavy weight of the "white" medicine! Pfizer biosimilar Nyvepria (Pifegsting) approved by the U.S. FDA!

 Time of Update: 2020-06-16

preservatives skin care lead body lantus side effects cancer cancer research news common statin drugs

JUNE 12, 2020 /PRNewswire/ -- Pfizer has announced that the U.S Food and Drug Administration (FDA) has approved Nyvepria (pegfilstim-apgf, Perfiertin), a biosimilar to the heavy-duty "litre white" bra
Nat Med: Research to suppress AAV-related immune responses will drive rapid progress in gene therapy!

 Time of Update: 2020-06-16

cell nucleus diagram peptide therapy cost genetic test dogs reporter gene spark therapeutics

JUNE 14, 2020 /PRNewswire/ -- A team of researchers from Genethon, along with a team of researchers from CNRS/Inserm and Spark Therapeutics, recently announced in the journal Nature Medicine that they
Ann Rheum Dis: Lupus nephritis 1 year lack of EULAR/ERA-EDTA response can predict long-term kidney prognosis

 Time of Update: 2020-06-16

use peroxide 2 4 6 trinitrotoluene full steps nickel 3 16 equals daily use

Lupusnene nephritis (LN) requires a short-term predicted end point for chronic kidney disease (CKD) The study analyzed the treatment response over a year The study analyzed LN patients who underwent
Vaccines: Study reveals new targets for SARS-coV2 vaccine

 Time of Update: 2020-06-16

10 brands world single source paint zoetis vaccines what immune globulin 2 led lights

June 12, 2020 /PRNewswire/ -- BioValley BIOON/--- we still do not have a vaccine to prevent COVID-19 In addition, although several antiviral drugs have been tested, there is no result to show that any
JID: Researchers find new ways to treat eczema

 Time of Update: 2020-06-16

neem oil eczema primary composition journal local dry ice journal pest science young scientist journal

June 12, 2020 /PRNewswire/ --- Researchers at the University of British Columbia (UBC) and the Vancouver Coastal Health Institute (VCHRI) have identified a key enzyme that causes eczema that could lea
Neurospinal itis spectrum disorder (NMOSD) the first B-cell consumer! FDA approved CD19 single anti-Uplizna, Haussen Pharmaceuticals introduced to China!

 Time of Update: 2020-06-16

cin 2 3 drug delivery system test ph level brain food snacks cf treatment

JUNE 12, 2020 /PRNEWSWIRE/ -- VIELA BIO IS HEADQUARTERED IN GAITHERSBURG, MD., A BIOPHARMACEUTICAL COMPANY THAT IS SPUN OFF FROM MED IMMUNE, A GLOBAL BIOLOGICS RESEARCH AND DEVELOPMENT ARM OF ASTRAZEN

Go to Page

Immunology News

Sci Adv: Heavyweight! Chinese scientists' successful conversion of the spleen into a liver-like organ could solve the dilemma facing liver organ transplantation.

J Hosp Infect: Shocked! Viral DNA spreads rapidly on the surface of the hospital ward, remaining for more than 5 days!

New psoriasis drug! AbbVie Skyrizi head-to-head Phase III efficacy beat Novartis Cosentyx (good ness): Peel damage completely cleared more!

EU regulators begin review of LEO's IL-13 monoanti-tralokinumab to treat adhetular dermatitis

Ann Rheum Dis: Prevalence of COVID-19 in patients with chronic inflammatory and autoimmune rheumatism

AAD 2020:Phase 3 Clinically Proven IL-17A/IL-17F Monoantikizumab Treatment Psoriasis, Better Than IL-12/IL-23 Single Antiustekinumab

Rheumatoid arthritis (RA) first antibody drug coupling (ADC)! Abbvie ABBV-3373 Proof of Concept II study successfully!

Ann Rheum Dis: Effects of rheumatoid arthritis on major cardiovascular events in patients with coronary heart disease and non-coronary heart disease

Nat Microbiol: How to fight salmonella infection by targeting specific tissue proteases?

J Cutan Med Surg: Vaccination guidelines for immunosuppressive patients with immunosuppressive diseases

InD application for treatment of rheumatoid arthritis in interstitial stem cell BX-U001, approved by FDA

Clin Microbiol Infect: The Effect of Vaccines on Heterogeneous Adaptive Immunity

Ann Rheum Dis: Characteristics associated with COVID-19 hospitalization in patients with rheumatism

Arthritis Rheumatol: Incidence of COVID-19 in patients with rheumatic disease sedatiat ingested immunosuppressants

Sword refers to the heavy weight of the "white" medicine! Pfizer biosimilar Nyvepria (Pifegsting) approved by the U.S. FDA!

Nat Med: Research to suppress AAV-related immune responses will drive rapid progress in gene therapy!

Ann Rheum Dis: Lupus nephritis 1 year lack of EULAR/ERA-EDTA response can predict long-term kidney prognosis

Vaccines: Study reveals new targets for SARS-coV2 vaccine

JID: Researchers find new ways to treat eczema

Neurospinal itis spectrum disorder (NMOSD) the first B-cell consumer! FDA approved CD19 single anti-Uplizna, Haussen Pharmaceuticals introduced to China!